Outcomes of very high‐risk prostate cancer after radical prostatectomy: Validation study from 3 centers-Reference-Cited by-同舟云学术

Outcomes of very high‐risk prostate cancer after radical prostatectomy: Validation study from 3 centers

Published:2018-11-13 Issue:3 Volume:125 Page:391-397
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sundi Debasish¹^ORCID,Tosoian Jeffrey J.²,Nyame Yaw A.³,Alam Ridwan²^ORCID,Achim Mary⁴,Reichard Chad A.⁴,Li Jianbo³,Wilkins Lamont³,Schwen Zeyad²,Han Misop²,Davis John W.⁴,Klein Eric A.³,Schaeffer Edward M.⁵,Stephenson Andrew J.³,Ross Ashley E.⁶,Chapin Brian F.⁴

Affiliation:

1. Department of Urology Ohio State University Columbus Ohio

2. Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore Maryland

3. Glickman Urological Institute, Cleveland Clinic Cleveland Ohio

4. Department of Urology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Urology Northwestern University Feinberg School of Medicine Chicago Illinois

6. Texas Oncology Dallas Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31833

Reference22 articles.

1. Cancer Statistics, 2008

2. Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the Literature

3. National Comprehensive Cancer Network.NCCN guidelines: prostate cancer 1.2017.https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed September 2017.

4. High-risk prostate cancer in the United States, 1990–2007

5. Very-high-risk localized prostate cancer: definition and outcomes

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high‐risk prostate cancer who underwent robot‐assisted radical prostatectomy;International Journal of Urology;2024-09-10

2. snRNAs from Radical Prostatectomy Specimens Have the Potential to Serve as Prognostic Factors for Clinical Recurrence after Biochemical Recurrence in Patients with High-Risk Prostate Cancer;Cancers;2024-05-01

3. Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer;Current Treatment Options in Oncology;2024-01

4. Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center;Radiotherapy and Oncology;2023-11

5. Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial;JNCI: Journal of the National Cancer Institute;2023-09-07